Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 45.77B P/E 35.67 EPS this Y -11.60% Ern Qtrly Grth -86.50%
Income 1.12B Forward P/E 18.97 EPS next Y 7.90% 50D Avg Chg -6.00%
Sales 15.48B PEG 13.78 EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 2.26 EPS next 5Y 1.45% 52W High Chg -14.00%
Recommedations 2.60 Quick Ratio 0.55 Shares Outstanding 1.92B 52W Low Chg 6.00%
Insider Own 0.02% ROA 6.97% Shares Float 1.91B Beta -
Inst Own 101.33% ROE 10.55% Shares Shorted/Prior 41.18M/44.75M Price 23.90
Gross Margin 57.51% Profit Margin 7.23% Avg. Volume 6,846,304 Target Price 22.76
Oper. Margin 17.88% Earnings Date Oct 24 Volume 15,999,131 Change 1.06%
About Kenvue Inc.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Kenvue Inc. News
12/12/24 An Intrinsic Calculation For Kenvue Inc. (NYSE:KVUE) Suggests It's 33% Undervalued
11/25/24 Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
11/15/24 There May Be Reason For Hope In Kenvue's (NYSE:KVUE) Disappointing Earnings
11/11/24 3 US Stocks Estimated Up To 31.4% Below Intrinsic Value
11/10/24 Kenvue Third Quarter 2024 Earnings: EPS Misses Expectations
11/08/24 Kenvue Inc (KVUE) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Market Challenges
11/07/24 Kenvue Inc. (KVUE): Expanded Production and Trusted Brands Drive Growth
11/07/24 Kenvue (KVUE) Q3 2024 Earnings Call Transcript
11/07/24 Kenvue's falling skin health sales hit earnings again
11/07/24 Kenvue Reports Third Quarter 2024 Results
11/04/24 Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines
10/31/24 Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
10/25/24 The Score: McDonald’s, Tesla, Spirit Airlines and More Stocks That Defined the Week
10/22/24 Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
10/22/24 Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
10/22/24 Starboard Focused on Kenvue's Struggling Unit
10/22/24 Starboard says Kenvue's skin health segment weighing on performance
10/21/24 Starboard Value Buys Into Dow Jones Spinoff; ELF Beauty Rallies
10/21/24 Kenvue stock jumps on reports of Starboard Value's stake
10/20/24 What’s News: Business & Finance
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ALLISON RICHARD E JR Director Director Aug 30 Buy 22.9589 5,598 128,524 25,598 08/31/23